Creative Medical Technolo... (CELZ)
NASDAQ: CELZ
· Real-Time Price · USD
2.02
0.00 (0.00%)
At close: May 19, 2025, 3:59 PM
2.02
0.00%
After-hours: May 19, 2025, 04:00 PM EDT
Company Description
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments.
The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility.
Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Creative Medical Technology Inc.
| Country | United States |
| IPO Date | Nov 6, 2015 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Timothy Warbington |
Contact Details
Address: 211 East Osborn Road Phoenix, Arizona United States | |
| Website | https://www.creativemedicaltechnology.com |
Stock Details
| Ticker Symbol | CELZ |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001187953 |
| CUSIP Number | 22529Y200 |
| ISIN Number | US22529Y4089 |
| Employer ID | 87-0622284 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Timothy Warbington | Co-Founder, Chairman, President & Chief Executive Officer |
| Donald F. Dickerson MBA | Senior Vice President, Chief Financial Officer & Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 15, 2025 | SCHEDULE 13G | Filing |
| May 09, 2025 | 10-Q | Quarterly Report |
| May 06, 2025 | 8-K | Current Report |
| Apr 25, 2025 | 10-K/A | [Amend] Annual Report |
| Apr 15, 2025 | 424B3 | Filing |
| Apr 11, 2025 | 8-K | Current Report |
| Apr 04, 2025 | 10-K/A | [Amend] Annual Report |
| Apr 02, 2025 | S-3 | Filing |
| Mar 19, 2025 | 10-K/A | [Amend] Annual Report |
| Mar 17, 2025 | DEF 14A | Filing |